Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leyvraz

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|August 2, 1994
[Primary and adjuvant treatment of breast cancer: an update]L Perey, S Leyvraz
Praxis|March 1, 1995
[High-dose chemotherapy with hematopoietic salvage in patients with breast cancer]L Perey, S Leyvraz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Radionuclide targeting of bone metastases: which efficacy?S Leyvraz, P Burckhardt
Revue Medicale Suisse|June 29, 2007
[Regional hospital, clinic, and physician collaboration in oncology care]A P Sappino, S Leyvraz
Blood|September 10, 1998
Apoptotic regulation in primitive hematopoietic precursorsR Peters, S Leyvraz, L Perey
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Paraneoplastic neurologic syndromesJ Bauer, T Kuntzer, S Leyvraz
Journal of the National Cancer Institute|January 15, 1997
A rare case of prednimustine-induced myoclonusC Monnerat, M Gander, S Leyvraz
Current Opinion in Oncology|March 1, 1993
Disseminated melanoma, preclinical therapeutic studies, clinical trials, and patient treatmentF Lejeune, J Bauer, S Leyvraz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Reverse transcriptase-polymerase chain reaction and islet cell carcinoma: not antagonist, but complementary toolsJ Benhattar, L Perey, R Peters, et al.
The Lancet. Oncology|March 22, 2002
Current and future developments in the use of temozolomide for the treatment of brain tumoursR Stupp, M Gander, S Leyvraz, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|August 2, 1994
[Primary and adjuvant treatment of breast cancer: an update]L Perey, S Leyvraz
Praxis|March 1, 1995
[High-dose chemotherapy with hematopoietic salvage in patients with breast cancer]L Perey, S Leyvraz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Radionuclide targeting of bone metastases: which efficacy?S Leyvraz, P Burckhardt
Revue Medicale Suisse|June 29, 2007
[Regional hospital, clinic, and physician collaboration in oncology care]A P Sappino, S Leyvraz
Blood|September 10, 1998
Apoptotic regulation in primitive hematopoietic precursorsR Peters, S Leyvraz, L Perey
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Paraneoplastic neurologic syndromesJ Bauer, T Kuntzer, S Leyvraz
Journal of the National Cancer Institute|January 15, 1997
A rare case of prednimustine-induced myoclonusC Monnerat, M Gander, S Leyvraz
Current Opinion in Oncology|March 1, 1993
Disseminated melanoma, preclinical therapeutic studies, clinical trials, and patient treatmentF Lejeune, J Bauer, S Leyvraz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Reverse transcriptase-polymerase chain reaction and islet cell carcinoma: not antagonist, but complementary toolsJ Benhattar, L Perey, R Peters, et al.
The Lancet. Oncology|March 22, 2002
Current and future developments in the use of temozolomide for the treatment of brain tumoursR Stupp, M Gander, S Leyvraz, et al.
Pageof 11